Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00019760
Status:
COMPLETED
Last Update Posted:
2023-10-31
First Post:
2007-03-02
Brief Title:
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
Sponsor:
National Institutes of Health Clinical Center CC
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Colon Cancer |
| Recurrent Colon Cancer |
| Liver Metastases |
| Stage IV Rectal Cancer |
| Recurrent Rectal Cancer |
Keywords:
| Name | View |
|---|---|
| unclassifiedother cancer | View |
| adult solid tumor | View |
| body systemsite cancer | View |
| cancer | View |
| colon cancer | View |
| colorectal cancer | View |
| gastrointestinal cancer | View |
| genetic condition | View |
| liver and intrahepatic biliary tract cancer | View |
| liver metastases | View |
| metastatic cancer | View |
| rectal cancer | View |
| recurrent colon cancer | View |
| recurrent rectal cancer | View |
| site metastatic cancer | View |
| solid tumor | View |
| stage IV colon cancer | View |
| stage IV rectal cancer | View |
| stage colon cancer | View |
| stage rectal cancer | View |